405 related articles for article (PubMed ID: 37492224)
61. Breast Cancer Stem Cells and Sex Steroid Hormones.
Flores-Ramírez I; Baranda-Avila N; Langley E
Curr Stem Cell Res Ther; 2019; 14(5):398-404. PubMed ID: 30095060
[TBL] [Abstract][Full Text] [Related]
62. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
63. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
Horne GA; Copland M
Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
[TBL] [Abstract][Full Text] [Related]
64. Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies.
Sonbol MB; Ahn DH; Bekaii-Saab T
Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30857342
[TBL] [Abstract][Full Text] [Related]
65. Targeting cancer stem cells in solid tumors by vitamin D.
So JY; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
[TBL] [Abstract][Full Text] [Related]
66. Regulation of breast cancer stem cell features.
Czerwinska P; Kaminska B
Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
[TBL] [Abstract][Full Text] [Related]
67. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
Du FY; Zhou QF; Sun WJ; Chen GL
World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
[TBL] [Abstract][Full Text] [Related]
68. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
69. The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
Rodriguez D; Ramkairsingh M; Lin X; Kapoor A; Major P; Tang D
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336602
[TBL] [Abstract][Full Text] [Related]
70. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
[TBL] [Abstract][Full Text] [Related]
71. Natural Products That Target Cancer Stem Cells.
Moselhy J; Srinivasan S; Ankem MK; Damodaran C
Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
[TBL] [Abstract][Full Text] [Related]
72. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
73. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
Manni W; Min W
MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
[TBL] [Abstract][Full Text] [Related]
74. LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells.
Flores-Huerta N; Silva-Cázares MB; Arriaga-Pizano LA; Prieto-Chávez JL; López-Camarillo C
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802575
[TBL] [Abstract][Full Text] [Related]
75. A Novel Long Non-Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis.
Qin Y; Hou Y; Liu S; Zhu P; Wan X; Zhao M; Peng M; Zeng H; Li Q; Jin T; Cui X; Liu M
Adv Sci (Weinh); 2021 Jan; 8(2):2002232. PubMed ID: 33511005
[TBL] [Abstract][Full Text] [Related]
76. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
[TBL] [Abstract][Full Text] [Related]
77. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
78. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
79. Strategy of differentiation therapy: effect of dual-frequency ultrasound on the induction of liver cancer stem-like cells on a HA-based multilayer film system.
Lee IC; Fadera S; Liu HL
J Mater Chem B; 2019 Sep; 7(35):5401-5411. PubMed ID: 31414097
[TBL] [Abstract][Full Text] [Related]
80. Breast cancer stem cells, EMT and therapeutic targets.
Kotiyal S; Bhattacharya S
Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
